Skip to main content

Table 1 Patient and tumor characteristics

From: A retrospective study of external beam radiation, neutron brachytherapy, and concurrent chemotherapy for patients with localized advanced carcinoma of the esophagus

Characteristics

Total (%)

TS

PF

p value

Gender

   

0.395

Male

84(60.0)

30(55.6)

54(62.8)

 

Female

56(40.0)

24(44.4)

32(37.2)

 

Age(years)

   

0.028

≤65

86(61.4)

27(50.0)

59(68.6)

 

>65

54(38.6)

27(50.0)

27(31.4)

 

The length

   

0.354

≤5 cm

58(41.4)

25(46.3)

33(38.4)

 

>5 cm

82(58.6)

29(53.7)

53(61.6)

 

Tumor location

   

0.800

Upper

33(23.6)

11(20.4)

22(25.6)

 

Middle

92(65.7)

38(70.4)

54(62.8)

 

Lower

15(11.7)

5(9.2)

10(11.6)

 

T stage

   

0.026

 T2

22(15.7)

13(24.1)

9(10.5)

 

 T3

51(36.4)

22(40.7)

29(33.7)

 

 T4

67(47.9)

19(35.2)

48(55.8)

 

N stage

   

0.002

 N0

68(48.6)

35(64.8)

33(38.4)

 

 N1

72(51.4)

19(35.2)

53(61.6)

 

6th AJCC stage

   

0.007

 Iia

43(30.7)

24(44.4)

19(22.1)

 

 Iib

7(5.0)

4(7.4)

3(3.5)

 

 III

90(64.3)

26(48.2)

64(74.4)

 

 RT Dose

   

0.809

 ≤66 Gy

89(63.6)

35(64.8)

54(62.8)

 

 ≥67 Gy

51(36.4)

19(44.4)

32(37.2)

 
  1. Abbreviations: CRT = chemotherapy plus radiotherapy; RT = radiotherapy alone; OS = Overall survival rate; LCR = local control rate.